NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
Estimated value
£72.0m
Awarded value
£72.0m
Awarded 19 Jun 2018
Suppliers
1
Lots
1
1 awarded
Published
16 Jul 2018
Deadline 28 Mar 2018
Description
NHS Framework Agreement for the supply of Icatibant and C1-Esterase products for the treatment of Hereditary Angioedema. The framework will commence on 1st July 2018 for a period of 12 months until 30th June 2019, with options to extend up to a further 36 months.
Scope
- Reference
- tender_164721/687468
- Total value
- £72,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2018 to 29 Jun 2019
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 28 Mar 2018, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£72.0m
Award date
19 Jun 2018
Contract start
30 Jun 2018
Contract end
29 Jun 2019